Keith Kowalczyk, MD, is the Interim Physician Executive Director, MedStar Health Urology and the Interim Chair, Department of Urology at MedStar Georgetown University Hospital. He is board certified in urology, with training in urologic oncology and robotic-assisted surgery. He sees patients at MedStar's Pasquerilla Healthcare Center at MedStar Georgetown in Washington, D.C., as well as MedStar's clinic in Chevy Chase.
Dr. Kowalczyk treats a full range of urologic conditions, but focuses on kidney, testicular, bladder, and prostate cancers. While skilled in performing traditional open surgery, his special expertise is in robotic-assisted surgery, and he has performed hundreds of procedures using this technology.
Dr. Kowalczyk is one of the few urologic surgeons in the D.C. metro area with specific expertise and training in urologic robotic surgery for urologic cancers.For those not familiar with robotic surgery, the surgeon uses special instruments controlled through a robotic/computer console which allows increased range of motion and often more precision than traditional surgical instruments. The camera he uses provides 10 to 12 times more magnification than traditional cameras used in surgery.
With his experience in performing robotic surgery, Dr. Kowalczyk is able to perform a more precise surgery with generally fewer complications. Also, Dr. Kowalczyk is able to offer more options for certain high-risk patients, like obese men who need prostatectomy surgery as well as patients with large kidney masses who have been told their kidney requires removal. With the magnified view and precision of robotic surgery, these patients have the options of minimally invasive procedures and better outcomes.
Dr. Kowalczyk is also actively involved in health services research on cancer treatments, outcomes, and patterns and costs of care and has authored numerous peer-reviewed articles on these topics.
The burden of skeletal-related events in patients with prostate cancer and bone metastasis. Roghmann F, Antczak C, McKay RR, Choueiri T, Hu JC, Kibel AS, Kim SP, Kowalczyk KJ, Menon M, Nguyen PL, Saad F, Sammon JD, Schmid M, Sukumar S, Sun M, Noldus J, Trinh QD. Urol Oncol. 2015 Jan;33(1):17.e9-18.
Is there any evidence of a "July effect" in patients undergoing major cancer surgery?
Ravi P, Trinh VQ, Sun M, Sammon J, Sukumar S, Gervais MK, Shariat SF, Kim SP, Kowalczyk KJ, Hu JC, Menon M, Karakiewicz PI, Trinh QD. Can J Surg. 2014 Apr;57(2):82-8.
Optimal timing of early versus delayed adjuvant radiotherapy following radical prostatectomy for locally advanced prostate cancer. Kowalczyk KJ, Gu X, Nguyen PL, Lipsitz SR, Trinh QD, Lynch JH, Collins SP, Hu JC. Urol Oncol. 2014 Apr;32(3):303-8. doi: 10.1016/j.urolonc.2013.09.004.
Robotic-assisted prostatectomy and open radical retropubic prostatectomy for locally-advanced prostate cancer: multi-institution comparison of oncologic outcomes. Vora AA, Marchalik D, Kowalczyk KJ, Nissim H, Bandi G, McGeagh KG, Lynch JH, Ghasemian SR, Verghese M, Venkatesan K, Borges P, Uchio EM, Hwang JJ. Prostate Int. 2013;1(1):31-6.
Venous thromboembolism after major cancer surgery: temporal trends and patterns of care. Trinh VQ, Karakiewicz PI, Sammon J, Sun M, Sukumar S, Gervais MK, Shariat SF, Tian Z, Kim SP,Kowalczyk KJ, Hu JC, Menon M, Trinh QD. JAMA Surg. 2014 Jan;149(1):43-9.
For a more publications by Dr. Kowalczyk's click here.
<iframe width="560" height="315" src="https://www.youtube.com/embed/4LsxPZh9Ou8" title="YouTube video player" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>